Shehnaz Ahmed

Shehnaz Ahmed

Auto-generated profile, based on publicly available information

Shehnaz Ahmed

British Association of Dermatologists , London

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Skin Health and Disease
Verified
Journal Article
Open access
PDF file
MKM. Kwiatkowska
M. Kwiatkowska
SAS. Ahmed
S. Ahmed
MAM. Ardern-Jones
M. Ardern-Jones
LBL. A. Bhatti
L. A. Bhatti
TBT. O. Bleiker
T. O. Bleiker
ZVZ. C. Venables
Z. C. Venables
Introduction: The most common cancers in the UK are keratinocyte cancers (KCs): the combined term for basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (cSCCs). Registration of KC is challenging due to high numbers and multiplicity of tumours per person. Methods: We provide an updated report on the descriptive epidemiology of trends in KC incidence for the resident populations of UK countries (England, Northern Ireland, Scotland and Wales) using population-based cancer registry and pathology report data, 2013–18. Results: Substantial increases in cSCC incidence in England, Scotland and Northern Ireland can be detected for the period of 2013–18, and the incidence of cSCC also increased in Wales from 2016 to 2018. In contrast, however, the pattern of annual change in the incidence of BCC across the nations differs. In England, the incidence of BCC declined slightly from 2016 to 2018, however, the overall trend across 2013–18 is not statistically significant. In Scotland, the incidence of BCC shows some variability, declining in 2017 before increasing in 2018, and the overall trend across 2013–18 was also not statistically significant. In Northern Ireland, the incidence of BCC increased significantly over the study period, and in Wales, the incidence of BCC increased from 2016 to 2018. One in five people will develop non-melanoma skin cancers (NMSC) in their lifetime in England. This estimate is much higher than the lifetime risk of melanoma (1 in 36 males and 1 in 47 females born after 1960 in the UK), which further highlights the burden of the disease and importance of early prevention strategies. Conclusions: We highlight how common these tumours are by publishing the first ever lifetime incidence of NMSC. Additionally, the first time reporting of the age standardised incidence of KC in Wales further confirms the scale of the disease burden posed by these cancers in the UK. With approximately one in five people developing NMSC in their lifetime, optimisation of skin cancer prevention, management and research are essential.

1 February 2025 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
MHMatthew Harries
Matthew Harries
YAYusur Al-Nuaimi
Yusur Al-Nuaimi
DWDmitri Wall
Dmitri Wall
ACAnne Chandidzura
Anne Chandidzura
SAShehnaz Ahmed
Shehnaz Ahmed
NMNekma Meah
Nekma Meah
The therapeutic landscape for alopecia areata (AA) is changing with the introduction of new therapeutic options, particularly the Janus kinase inhibitors. However, there is uncertainty from UK dermatologists around safe prescribing and the longer-term risk of these therapies. GRASS-UK (the Global Register of Alopecia areata disease Severity and treatment Safety – United Kingdom) is a national prospective AA disease register that will use real-world data to compare emerging therapies with existing treatments to better understand the safety and effectiveness of these new agents as they come to market.

26 September 2021 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
MKM.M. Kwiatkowska
M.M. Kwiatkowska
SAS. Ahmed
S. Ahmed
MAM.R. Ardern‐Jones
M.R. Ardern‐Jones
LBL.A. Bhatti
L.A. Bhatti
TBT.O. Bleiker
T.O. Bleiker
ZVZ.C. Venables
Z.C. Venables
Skin cancer is the commonest cancer in the UK. Skin cancer referrals via the two-week wait (urgent suspected cancer) pathway outnumber any other suspected malignancy.1, 2 The commonest skin cancers are keratinocyte cancers (KCs) which represents Basal Cell Carcinomas (BCC) and Cutaneous Squamous Cell Carcinomas (cSCC). Accurate KC incidence reporting is crucial for healthcare planning.

8 December 2019 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
SAS. Ahmed
S. Ahmed

23 May 2024 in British Journal of Dermatology
Verified
Journal Article
Closed access
JMJohn A McGrath
John A McGrath
SAShehnaz Ahmed
Shehnaz Ahmed

1 September 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SAS. Ahmed
S. Ahmed
ASA. Shipman
A. Shipman
GMG. Millington
G. Millington
ELEwan Langan
Ewan Langan
JIJohn R Ingram
John R Ingram